How Droplet Digital PCR Has Revolutionized Non-Invasive Plasma-Based Detection of Mutations

There is an unmet need for assays that monitor and detect the emergence of resistance mutations to targeted therapies, especially for advanced solid tumors where tissue availability is limiting. This case study from Bio-Rad describes how droplet digital PCR allows detection of EGFR T790M mutations in circulating tumor DNA.